CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 62 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06294730
NCT06294730N/ACompleted

Coronary Microcirculation and Troponin Elevation in Septic Shock

Karolinska Institutet·observational·Posted Mar 5, 2024·Updated Jun 29, 2025

In Brief

An observational study for Sepsis and 3 related conditions. Completed, enrolled 62 participants across 1 site.

Detailed Summary

Plasma cardiac troponin (cTn) elevation is an indicator of increased mortality in patients with sepsis yet the underlying cause of troponin elevation in sepsis is not known. The COMTESS study investigates whether elevated high-sensitive cardiac Troponin T (hs-cTnT) levels in hemodynamically unstable patients with sepsis can be explained by an underlying coronary artery disease or a process within the coronary microcirculation. Fifty patients with sepsis and with hs-cTnT elevation (\>15 ng/L) will undergo coronary angiography, including an assessment of coronary flow using a method called thermo-dilution to record the index of microcirculatory resistance (IMR) in the left anterior descending artery (LAD). The relationship between IMR and hs-cTnT will subsequently be analysed. It is important to identify the underlying causes of elevated cTn during sepsis to target further research with an aim to improve the survival in patients suffering from this condition.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesSweden
Collaborators--

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedMar 5, 2024
Enrollment StartJun 13, 2019
Primary CompletionDec 20, 2024
Study CompletionFeb 28, 2025
TodayJul 2, 2026
Enrollment to primary: 5.5 yearsPosted 2.3 years ago